242 related articles for article (PubMed ID: 10381041)
1. Modeling the lifetime costs of rheumatoid arthritis.
Gabriel SE; Crowson CS; Luthra HS; Wagner JL; O'Fallon WM
J Rheumatol; 1999 Jun; 26(6):1269-74. PubMed ID: 10381041
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
Osiri M; Maetzel A; Tugwell P
J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
[TBL] [Abstract][Full Text] [Related]
3. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
J Rheumatol; 1997 Jan; 24(1):43-8. PubMed ID: 9002009
[TBL] [Abstract][Full Text] [Related]
4. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
5. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
6. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
[TBL] [Abstract][Full Text] [Related]
7. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
8. Population-based mortality outcome of rheumatoid arthritis in females.
Iacovino JR
J Insur Med; 2002; 34(2):86-8. PubMed ID: 15305782
[TBL] [Abstract][Full Text] [Related]
9. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
Zhu TY; Tam LS; Li EK
Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs unique to people with arthritis.
Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
J Rheumatol; 1997 Apr; 24(4):719-25. PubMed ID: 9101508
[TBL] [Abstract][Full Text] [Related]
11. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
[TBL] [Abstract][Full Text] [Related]
12. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
[TBL] [Abstract][Full Text] [Related]
13. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.
Gabriel SE; Crowson CS; O'Fallon WM
Arthritis Rheum; 1999 Mar; 42(3):415-20. PubMed ID: 10088762
[TBL] [Abstract][Full Text] [Related]
15. The lifetime economic costs of rheumatoid arthritis.
Stone CE
J Rheumatol; 1984 Dec; 11(6):819-27. PubMed ID: 6520836
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period.
Doran MF; Pond GR; Crowson CS; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Mar; 46(3):625-31. PubMed ID: 11920397
[TBL] [Abstract][Full Text] [Related]
17. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
Nicola PJ; Crowson CS; Maradit-Kremers H; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2006 Jan; 54(1):60-7. PubMed ID: 16385496
[TBL] [Abstract][Full Text] [Related]
18. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
[TBL] [Abstract][Full Text] [Related]
19. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
20. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]